Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Eastern Cooperative Oncology Group (ECOG) performance status (PS) is a key clinical variable for cancer treatment and research, but it is usually only recorded in unstructured form in the electronic ...
Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.
Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
Cancer, a leading cause of death globally, accounts for over 10 million fatalities each year. While traditional cancer treatments, primarily focusing on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results